PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes

Reprogramming of energy metabolism is a key hallmark of cancer, which provides a new research perspective for exploring the development of cancer. However, the most critical target of anti-glycolytic therapy for ovarian cancer remains unclear. Therefore, in the present study, Oncomine, GEPIA, and HP...

Descripción completa

Detalles Bibliográficos
Autores principales: Gou, Rui, Hu, Yuexin, Liu, Ouxuan, Dong, Hui, Gao, Lingling, Wang, Shuang, Zheng, Mingjun, Li, Xiao, Lin, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281930/
https://www.ncbi.nlm.nih.gov/pubmed/34277429
http://dx.doi.org/10.3389/fonc.2021.682461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281930/
https://www.ncbi.nlm.nih.gov/pubmed/34277429
http://dx.doi.org/10.3389/fonc.2021.682461

Ejemplares similares